New Data Standards and Policies Aim to Spur Clinical Research

FDA encourages clinical data e-submission and boosting development of new therapies to combat bioterrorism, cancer, and obesity.

For full articale Click Here

Author(s): 
Jill Weschler
Journal: 
Applied Clinical Trials, Sep 1, 2004